{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:53:41Z","timestamp":1781276021150,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Chemotherapy-induced peripheral neuropathy  (CIPN), hand-foot syndrome (HFS), and nail changes are common adverse effects associated with chemotherapy, significantly impacting the quality of life of cancer patients, and effective interventions remain an unmet need in oncologic care. Regional limb cooling is an emerging non-pharmacological approach used to prevent or reduce the severity of these adverse side effects. Although the awareness of regional limb cooling is rather prevalent, the overall use and efficacy of this non-pharmacological therapy in preventing chemotoxicities is not universally agreed upon. This paper reviews the current evidence regarding the use, efficacy, limitations, and safety of regional limb cooling in preventing or reducing CIPN, HFS, and nail changes in clinical settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A literature review was conducted using the PubMed database to identify the most recent English articles published between 2004 and 2024 regarding the use of regional limb cooling to prevent CIPN, HFS, and nail changes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Based on the reviewed studies, regional limb cooling can potentially be a low-risk, non-pharmacological intervention that can prevent and reduce common and debilitating chemotherapy-induced toxicities. Although the studies described in this paper demonstrate encouraging results, there is still notable variability in efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This underscores the need for randomized controlled trials, device innovation, and standardized protocols in regional limb cooling to properly demonstrate its potential for alleviating these common, debilitating conditions and enabling patients to adhere to their chemotherapy regimens more comfortably. This would thereby enhance overall cancer treatment tolerability and lead to safer, more patient-centered chemotherapy management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09689-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T19:40:12Z","timestamp":1752176412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review"],"prefix":"10.1007","volume":"33","author":[{"given":"Teja","family":"Mallela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Dulmage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"1","key":"9689_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10549-023-07172-y","volume":"204","author":"MK Accordino","year":"2024","unstructured":"Accordino MK et al (2024) Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer. Breast Cancer Res Treat 204(1):49\u201359","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9689_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/1078155220959431","volume":"27","author":"AG Bailey","year":"2021","unstructured":"Bailey AG, Brown JN, Hammond JM (2021) Cryotherapy for the prevention of chemotherapy-induced peripheral neuropathy: a systematic review. J Oncol Pharm Pract 27(1):156\u2013164","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"9689_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/0284186X.2015.1075664","volume":"55","author":"A Bandla","year":"2016","unstructured":"Bandla A et al (2016) Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controls. Acta Oncol 55(4):430\u2013436","journal-title":"Acta Oncol"},{"issue":"8","key":"9689_CR4","first-page":"3691","volume":"28","author":"A Bandla","year":"2020","unstructured":"Bandla A et al (2020) Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy. Support Care Cancer 28(8):3691\u20133699","journal-title":"Support Care Cancer"},{"key":"9689_CR5","doi-asserted-by":"publisher","first-page":"573234","DOI":"10.3389\/fdgth.2020.573234","volume":"2","author":"J Binder","year":"2020","unstructured":"Binder J et al (2020) A limb hypothermia wearable for chemotherapy-induced peripheral neuropathy: a mixed-methods approach in medical product development. Front Digit Health 2:573234","journal-title":"Front Digit Health"},{"key":"9689_CR6","doi-asserted-by":"publisher","first-page":"103763","DOI":"10.1016\/j.breast.2024.103763","volume":"76","author":"C Brunner","year":"2024","unstructured":"Brunner C et al (2024) Cropsi study: efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer-a prospective, randomized trial. Breast 76:103763","journal-title":"Breast"},{"issue":"7","key":"9689_CR7","first-page":"2161","volume":"26","author":"S Bun","year":"2018","unstructured":"Bun S et al (2018) Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer. Support Care Cancer 26(7):2161\u20132166","journal-title":"Support Care Cancer"},{"issue":"12","key":"9689_CR8","first-page":"10001","volume":"30","author":"A Chan","year":"2022","unstructured":"Chan A et al (2022) A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy. Support Care Cancer 30(12):10001\u201310007","journal-title":"Support Care Cancer"},{"issue":"6","key":"9689_CR9","first-page":"4835","volume":"30","author":"P Chitkumarn","year":"2022","unstructured":"Chitkumarn P, Rahong T, Achariyapota V (2022) Efficacy of Siriraj, in-house-developed, frozen gloves for cold therapy reduction of chemotherapy-induced peripheral neuropathy in gynecological cancer patients: randomized controlled trial. Support Care Cancer 30(6):4835\u20134843","journal-title":"Support Care Cancer"},{"key":"9689_CR10","doi-asserted-by":"publisher","first-page":"107273","DOI":"10.1016\/j.cct.2023.107273","volume":"131","author":"SA Cohen","year":"2023","unstructured":"Cohen SA et al (2023) Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: study protocol for a randomized, controlled pilot and feasibility study. Contemp Clin Trials 131:107273","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"9689_CR11","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.esmoop.2023.101205","volume":"8","author":"A Coolbrandt","year":"2023","unstructured":"Coolbrandt A et al (2023) A randomized controlled trial of hand\/foot-cooling by Hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system. ESMO Open 8(2):101205","journal-title":"ESMO Open"},{"issue":"5","key":"9689_CR12","doi-asserted-by":"publisher","first-page":"E149","DOI":"10.1188\/20.ONF.E149-E160","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J et al (2020) Targeted therapy- and chemotherapy-associated skin toxicities: systematic review and meta-analysis. Oncol Nurs Forum 47(5):E149-e160","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"9689_CR13","doi-asserted-by":"publisher","first-page":"151673","DOI":"10.1016\/j.soncn.2024.151673","volume":"40","author":"K Ford","year":"2024","unstructured":"Ford K et al (2024) Distal-extremity cryotherapy in preventing chemotherapy-induced peripheral neuropathy from paclitaxel administration in people affected by breast cancer: a systematic review. Semin Oncol Nurs 40(4):151673","journal-title":"Semin Oncol Nurs"},{"key":"9689_CR14","doi-asserted-by":"publisher","first-page":"1216813","DOI":"10.3389\/fonc.2023.1216813","volume":"13","author":"C Funasaka","year":"2023","unstructured":"Funasaka C et al (2023) Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial. Front Oncol 13:1216813","journal-title":"Front Oncol"},{"issue":"3","key":"9689_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1078155208100450","volume":"15","author":"P Gilbar","year":"2009","unstructured":"Gilbar P, Hain A, Peereboom VM (2009) Nail toxicity induced by cancer chemotherapy. J Oncol Pharm Pract 15(3):143\u2013155","journal-title":"J Oncol Pharm Pract"},{"issue":"10","key":"9689_CR16","first-page":"3461","volume":"26","author":"C Griffiths","year":"2018","unstructured":"Griffiths C et al (2018) Cold therapy to prevent paclitaxel-induced peripheral neuropathy. Support Care Cancer 26(10):3461\u20133469","journal-title":"Support Care Cancer"},{"issue":"2","key":"9689_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jnci\/djx178","volume":"110","author":"A Hanai","year":"2018","unstructured":"Hanai A et al (2018) Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial. J Natl Cancer Inst 110(2):141\u2013148","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9689_CR18","first-page":"e13118","volume":"28","author":"KL Huang","year":"2019","unstructured":"Huang KL et al (2019) Prophylactic management for taxane-induced nail toxicity: a systematic review and meta-analysis. Eur J Cancer Care (Engl) 28(5):e13118","journal-title":"Eur J Cancer Care (Engl)"},{"key":"9689_CR19","doi-asserted-by":"publisher","first-page":"781812","DOI":"10.3389\/fonc.2021.781812","volume":"11","author":"J Jia","year":"2021","unstructured":"Jia J et al (2021) Cryotherapy for prevention of taxane-induced peripheral neuropathy: a meta-analysis. Front Oncol 11:781812","journal-title":"Front Oncol"},{"issue":"8","key":"9689_CR20","first-page":"554","volume":"32","author":"K Johnson","year":"2024","unstructured":"Johnson K et al (2024) Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison. Support Care Cancer 32(8):554","journal-title":"Support Care Cancer"},{"issue":"1","key":"9689_CR21","first-page":"93","volume":"26","author":"MY Jue","year":"2022","unstructured":"Jue MY et al (2022) Impact of cold therapy on paclitaxel-induced peripheral neuropathy and quality of life in patients with breast cancer. Clin J Oncol Nurs 26(1):93\u201399","journal-title":"Clin J Oncol Nurs"},{"issue":"2","key":"9689_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/IGC.0b013e31827c18f3","volume":"23","author":"JM Julius","year":"2013","unstructured":"Julius JM et al (2013) Evaluation of pegylated liposomal doxorubicin dose on the adverse drug event profile and outcomes in treatment of recurrent endometrial cancer. Int J Gynecol Cancer 23(2):348\u2013354","journal-title":"Int J Gynecol Cancer"},{"key":"9689_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.breast.2019.12.011","volume":"49","author":"Y Kanbayashi","year":"2020","unstructured":"Kanbayashi Y et al (2020) Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a prospective self-controlled trial. Breast 49:219\u2013224","journal-title":"Breast"},{"issue":"10","key":"9689_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12032-022-01754-4","volume":"39","author":"Y Kanbayashi","year":"2022","unstructured":"Kanbayashi Y et al (2022) Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial. Med Oncol 39(10):153","journal-title":"Med Oncol"},{"issue":"5","key":"9689_CR25","doi-asserted-by":"publisher","first-page":"151685","DOI":"10.1016\/j.soncn.2024.151685","volume":"40","author":"G Kanzawa-Lee","year":"2024","unstructured":"Kanzawa-Lee G, Krauss JC, Knoerl R (2024) Exploring chemotherapy-induced peripheral neuropathy management practice patterns among oncology clinicians. Semin Oncol Nurs 40(5):151685","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"9689_CR26","first-page":"15","volume":"11","author":"N Klafke","year":"2023","unstructured":"Klafke N, Bossert J, Kr\u00f6ger B, Neuberger P, Heyder U, Layer M, Winkler M, Idler C, Kaschdailewitsch E, Heine R, John H (2023) Prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN) with non-pharmacological interventions: clinical recommendations from a systematic scoping review and an expert consensus process. Med Sci 11(1):15","journal-title":"Med Sci"},{"issue":"14","key":"9689_CR27","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3390\/cancers16142571","volume":"16","author":"KT Lee","year":"2024","unstructured":"Lee KT, Bulls HW, Hoogland AI, James BW, Colon-Echevarria CB, Jim HS (2024) Chemotherapy-induced peripheral neuropathy (CIPN): a narrative review and proposed theoretical model. Cancers 16(14):2571","journal-title":"Cancers"},{"key":"9689_CR28","first-page":"10","volume":"1","author":"R Li","year":"2022","unstructured":"Li R, Liu Y, Xue R, Wang Y, Zhao F, Chen L, Liu JE (2022) Effectiveness of nonpharmacologic interventions for chemotherapy-induced peripheral neuropathy in patients with breast cancer: a systematic review and network meta-analysis. Cancer Nurs 1:10\u201397","journal-title":"Cancer Nurs"},{"issue":"2","key":"9689_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ygyno.2007.10.021","volume":"108","author":"G Mangili","year":"2008","unstructured":"Mangili G et al (2008) Prevention strategies in palmar-plantar erythrodysesthesia onset: the role of regional cooling. Gynecol Oncol 108(2):332\u2013335","journal-title":"Gynecol Oncol"},{"issue":"12","key":"9689_CR30","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","volume":"154","author":"DH Marks","year":"2018","unstructured":"Marks DH, Qureshi A, Friedman A (2018) Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review. JAMA Dermatol 154(12):1465\u20131472","journal-title":"JAMA Dermatol"},{"issue":"4","key":"9689_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.clbc.2023.03.004","volume":"23","author":"C Mazzega-Fabbro","year":"2023","unstructured":"Mazzega-Fabbro C et al (2023) Mild cryotherapy for prevention of paclitaxel-induced nail toxicity in breast cancer patients: a phase II single-arm clinical trial. Clin Breast Cancer 23(4):447\u2013453","journal-title":"Clin Breast Cancer"},{"key":"9689_CR32","doi-asserted-by":"publisher","first-page":"e390428","DOI":"10.1200\/EDBK_390428","volume":"43","author":"A Michel","year":"2023","unstructured":"Michel A et al (2023) Improving quality of life during chemotherapy: cannabinoids, cryotherapy, and scalp cooling. Am Soc Clin Oncol Educ Book 43:e390428","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"9689_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygyno.2004.02.019","volume":"93","author":"KL Molpus","year":"2004","unstructured":"Molpus KL et al (2004) The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma. Gynecol Oncol 93(2):513\u2013516","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9689_CR34","doi-asserted-by":"publisher","first-page":"11575","DOI":"10.1038\/s41598-022-13327-6","volume":"12","author":"A Morrison","year":"2022","unstructured":"Morrison A et al (2022) A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer. Sci Rep 12(1):11575","journal-title":"Sci Rep"},{"issue":"5","key":"9689_CR35","first-page":"283","volume":"31","author":"K Nara","year":"2023","unstructured":"Nara K et al (2023) Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin. Support Care Cancer 31(5):283","journal-title":"Support Care Cancer"},{"key":"9689_CR36","doi-asserted-by":"publisher","first-page":"153473542094328","DOI":"10.1177\/1534735420943287","volume":"19","author":"E Oneda","year":"2020","unstructured":"Oneda E et al (2020) Innovative approach for the prevention of chemotherapy-induced peripheral neuropathy in cancer patients: a pilot study with the Hilotherm device, the Poliambulanza Hospital experience. Integr Cancer Ther 19:1534735420943287","journal-title":"Integr Cancer Ther"},{"issue":"5","key":"9689_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1188\/19.CJON.522-528","volume":"23","author":"L Peyton","year":"2019","unstructured":"Peyton L, Fischer-Cartlidge E (2019) Extremity cooling: a synthesis of cryotherapy interventions to reduce peripheral neuropathy and nail changes from taxane-based chemotherapy. Clin J Oncol Nurs 23(5):522\u2013528","journal-title":"Clin J Oncol Nurs"},{"key":"9689_CR38","first-page":"1","volume":"41","author":"RA Popescu","year":"2021","unstructured":"Popescu RA et al (2021) Supportive care: low cost, high value. Am Soc Clin Oncol Educ Book 41:1\u201311","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"9689_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.23736\/S1973-9087.24.08197-8","volume":"60","author":"G Ronconi","year":"2024","unstructured":"Ronconi G et al (2024) Conservative non-pharmacological treatments for chemotherapy-induced peripheral neuropathies in women treated for breast cancer: a systematic review. Eur J Phys Rehabil Med 60(3):505\u2013513","journal-title":"Eur J Phys Rehabil Med"},{"issue":"8","key":"9689_CR40","first-page":"3763","volume":"28","author":"F Rosenbaek","year":"2020","unstructured":"Rosenbaek F et al (2020) Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast cancer. Support Care Cancer 28(8):3763\u20133769","journal-title":"Support Care Cancer"},{"key":"9689_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2019.09.011","volume":"48","author":"KJ Ruddy","year":"2019","unstructured":"Ruddy KJ et al (2019) Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. Breast 48:89\u201397","journal-title":"Breast"},{"key":"9689_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40780-016-0067-2","volume":"2","author":"J Sato","year":"2016","unstructured":"Sato J et al (2016) The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy. J Pharm Health Care Sci 2:33","journal-title":"J Pharm Health Care Sci"},{"issue":"16","key":"9689_CR43","doi-asserted-by":"publisher","first-page":"e33580","DOI":"10.1097\/MD.0000000000033580","volume":"102","author":"H Shigematsu","year":"2023","unstructured":"Shigematsu H et al (2023) Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy. Medicine (Baltimore) 102(16):e33580","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"9689_CR44","first-page":"845","volume":"11","author":"BG Sphar","year":"2020","unstructured":"Sphar BG, Bowe C, Dains JE (2020) The impact of peripheral cooling on chemotherapy-induced peripheral neuropathy: an integrative review. J Adv Pract Oncol 11(8):845\u2013857","journal-title":"J Adv Pract Oncol"},{"key":"9689_CR45","first-page":"274","volume":"6","author":"R Sundar","year":"2016","unstructured":"Sundar R et al (2016) Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: a pilot study. Front Oncol 6:274","journal-title":"Front Oncol"},{"issue":"7","key":"9689_CR46","first-page":"482","volume":"32","author":"HY Tai","year":"2024","unstructured":"Tai HY et al (2024) Efficacy of cryotherapy in the prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Support Care Cancer 32(7):482","journal-title":"Support Care Cancer"},{"key":"9689_CR47","doi-asserted-by":"publisher","first-page":"104244","DOI":"10.1016\/j.critrevonc.2023.104244","volume":"194","author":"M Tandon","year":"2024","unstructured":"Tandon M et al (2024) Cryotherapy for prevention of chemotherapy induced peripheral neuropathy in breast cancer. Crit Rev Oncol Hematol 194:104244","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"9689_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ygyno.2009.04.007","volume":"114","author":"JL Tanyi","year":"2009","unstructured":"Tanyi JL et al (2009) Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer. Gynecol Oncol 114(2):219\u2013224","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9689_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-018-4788-9","volume":"171","author":"R Thomas","year":"2018","unstructured":"Thomas R et al (2018) A double-blind, randomised trial of a polyphenolic-rich nail bed balm for chemotherapy-induced onycholysis: the UK polybalm study. Breast Cancer Res Treat 171(1):103\u2013110","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9689_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejon.2006.10.004","volume":"11","author":"JD Webster-Gandy","year":"2007","unstructured":"Webster-Gandy JD, How C, Harrold K (2007) Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs 11(3):238\u2013246","journal-title":"Eur J Oncol Nurs"},{"issue":"8","key":"9689_CR51","first-page":"468","volume":"31","author":"C Wegge-Larsen","year":"2023","unstructured":"Wegge-Larsen C, Mehlsen M, Jensen AB (2023) The motivation of breast cancer patients to participate in a national randomized control trial. Support Care Cancer 31(8):468","journal-title":"Support Care Cancer"},{"key":"9689_CR52","doi-asserted-by":"publisher","first-page":"1366782","DOI":"10.3389\/fonc.2024.1366782","volume":"14","author":"H Wu","year":"2024","unstructured":"Wu H et al (2024) Effect of frozen gloves on chemotherapy-induced neurotoxicity in breast cancer patients: a systematic review and meta-analysis. Front Oncol 14:1366782","journal-title":"Front Oncol"},{"issue":"6","key":"9689_CR53","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1097\/MS9.0000000000000906","volume":"85","author":"M Xu","year":"2023","unstructured":"Xu M et al (2023) Efficacy of cryotherapy on chemotherapy-induced peripheral neuropathy in patients with breast cancer: a propensity score-matched study. Ann Med Surg (Lond) 85(6):2695\u20132703","journal-title":"Ann Med Surg (Lond)"},{"issue":"4","key":"9689_CR54","doi-asserted-by":"publisher","first-page":"e13094","DOI":"10.1111\/ijn.13094","volume":"29","author":"TT Yang","year":"2023","unstructured":"Yang TT, Pai HC, Chen CY (2023) Effect of cryotherapy on paclitaxel-induced peripheral neuropathy of the hand in female breast cancer patients: a prospective self-controlled study. Int J Nurs Pract 29(4):e13094","journal-title":"Int J Nurs Pract"},{"issue":"33","key":"9689_CR55","doi-asserted-by":"publisher","first-page":"10075","DOI":"10.12998\/wjcc.v9.i33.10075","volume":"9","author":"YF Zheng","year":"2021","unstructured":"Zheng YF et al (2021) Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients. World J Clin Cases 9(33):10075\u201310087","journal-title":"World J Clin Cases"},{"issue":"3","key":"9689_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/ejhpharm-2020-002311","volume":"28","author":"Y Zhu","year":"2020","unstructured":"Zhu Y et al (2020) Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects. Eur J Hosp Pharm 28(3):124\u2013128","journal-title":"Eur J Hosp Pharm"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09689-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:40:56Z","timestamp":1757223656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09689-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["9689"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09689-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"678"}}